JUN and cancer: Activation of the PI3K/AKT pathway promotes the mechanistic target of rapamycin (mTOR), effectors of which include hypoxia-inducible factor 1 (HIF-1), activator protein 1 (AP-1), and nuclear factor kappa B (NF-κB) that play an important role in promoting cancer.